39,009 research outputs found

    Direction-of-Arrival Estimation Based on Sparse Recovery with Second-Order Statistics

    Get PDF
    Traditional direction-of-arrival (DOA) estimation techniques perform Nyquist-rate sampling of the received signals and as a result they require high storage. To reduce sampling ratio, we introduce level-crossing (LC) sampling which captures samples whenever the signal crosses predetermined reference levels, and the LC-based analog-to-digital converter (LC ADC) has been shown to efficiently sample certain classes of signals. In this paper, we focus on the DOA estimation problem by using second-order statistics based on the LC samplings recording on one sensor, along with the synchronous samplings of the another sensors, a sparse angle space scenario can be found by solving an ell1ell_1 minimization problem, giving the number of sources and their DOA's. The experimental results show that our proposed method, when compared with some existing norm-based constrained optimization compressive sensing (CS) algorithms, as well as subspace method, improves the DOA estimation performance, while using less samples when compared with Nyquist-rate sampling and reducing sensor activity especially for long time silence signal

    The 1982 ASEE-NASA Faculty Fellowship program (Aeronautics and Research)

    Get PDF
    The NASA/ASEE Summer Faculty Fellowship Program (Aeronautics and Research) conducted at the NASA Goddard Space Flight Center during the summer of 1982 is described. Abstracts of the Final Reports submitted by the Fellows detailing the results of their research are also presented

    Radio observations of the cool gas, dust, and star formation in the first galaxies

    Full text link
    We summarize cm through submm observations of the host galaxies of z ~ 6 quasars. These observations reveal the cool molecular gas (the fuel for star formation), the warm dust (heated by star formation), the fine structure line emission (tracing the CNM and PDRs), and the synchrotron emission. Our results imply active star formation in ~ 30% of the host galaxies, with star formation rates ~ 10^3 M_sun/year, and molecular gas masses ~ 10^10 M_sun. Imaging of the [CII] emission from the most distant quasar reveals a 'maximal starburst disk' on a scale ~ 1.5 kpc. Gas dynamical studies suggest a departure of these galaxies from the low-z M_{BH} -- M_{bulge} relation, with the black holes being, on average, 15 times more massive than expected. Overall, we are witnessing the co-eval formation of massive galaxies and supermassive black holes within 1 Gyr of the Big Bang.Comment: First Stars and Galaxies: Challenges in the Next Decade, AIP, 2010; Austin TX (eds Whelan, Bromm, Yoshida); 7 page

    Convexity and potential sums for Salpeter-like Hamiltonians

    Full text link
    The semirelativistic Hamiltonian H = \beta\sqrt{m^2 + p^2} + V(r), where V(r) is a central potential in R^3, is concave in p^2 and convex in p. This fact enables us to obtain complementary energy bounds for the discrete spectrum of H. By extending the notion of 'kinetic potential' we are able to find general energy bounds on the ground-state energy E corresponding to potentials with the form V = sum_{i}a_{i}f^{(i)}(r). In the case of sums of powers and the log potential, where V(r) = sum_{q\ne 0} a(q) sgn(q)r^q + a(0)ln(r), the bounds can all be expressed in the semi-classical form E \approx \min_{r}{\beta\sqrt{m^2 + 1/r^2} + sum_{q\ne 0} a(q)sgn(q)(rP(q))^q + a(0)ln(rP(0))}. 'Upper' and 'lower' P-numbers are provided for q = -1,1,2, and for the log potential q = 0. Some specific examples are discussed, to show the quality of the bounds.Comment: 21 pages, 4 figure

    Studying the first galaxies with ALMA

    Full text link
    We discuss observations of the first galaxies, within cosmic reionization, at centimeter and millimeter wavelengths. We present a summary of current observations of the host galaxies of the most distant QSOs (z6z \sim 6). These observations reveal the gas, dust, and star formation in the host galaxies on kpc-scales. These data imply an enriched ISM in the QSO host galaxies within 1 Gyr of the big bang, and are consistent with models of coeval supermassive black hole and spheroidal galaxy formation in major mergers at high redshift. Current instruments are limited to studying truly pathologic objects at these redshifts, meaning hyper-luminous infrared galaxies (LFIR1013L_{FIR} \sim 10^{13} L_\odot). ALMA will provide the one to two orders of magnitude improvement in millimeter astronomy required to study normal star forming galaxies (ie. Ly-α\alpha emitters) at z6z \sim 6. ALMA will reveal, at sub-kpc spatial resolution, the thermal gas and dust -- the fundamental fuel for star formation -- in galaxies into cosmic reionization.Comment: to appear in Science with ALMA: a new era for Astrophysics}, ed. R. Bachiller (Springer: Berlin); 5 pages, 7 figure

    Influence of tensor interactions on masses and decay widths of dibaryons

    Full text link
    The influence of gluon and Goldstone boson induced tensor interactions on the dibaryon masses and D-wave decay widths has been studied in the quark delocalization, color screening model. The effective S-D wave transition interactions induced by gluon and Goldstone boson exchanges decrease rapidly with increasing strangeness of the channel. The tensor contribution of K and η\eta mesons is negligible in this model. There is no six-quark state in the light flavor world studied so far that can become bound by means of these tensor interactions besides the deuteron. The partial D-wave decay widths of the IJp=1/22+IJ^p={1/2}2^+ NΩ\Omega state to spin 0 and 1 ΛΞ\Lambda\Xi final states are 12.0 keV and 21.9 keV respectively. This is a very narrow dibaryon resonance that might be detectable in relativistic heavy ion reactions by existing RHIC detectors through the reconstruction of the vertex mass of the decay product ΛΞ\Lambda\Xi and by the COMPAS detector at CERN or at JHF in Japan and the FAIR project in Germany in the future.Comment: 19 pages, 5 figure

    Data-driven model predictive control for power demand management and fast demand response of commercial buildings using support vector regression

    Get PDF
    Demand response (DR) of commercial buildings by directly shutting down part of operating chillers could provide an immediate power reduction for power grids. In this special fast DR event, effective control needs to guarantee expected power reduction and ensure an acceptable indoor environment. This study, therefore, developed a data-driven model predictive control (MPC) using support vector regression (SVR) for fast DR events. According to the characteristics of fast DR events, the optimized hyperparameters of SVR and shortened searching range of genetic algorithm are used to improve the control performance. Meanwhile, a comprehensive comparison with RC-based MPC is conducted based on three scenarios of power demand controls. Test results show that the proposed SVR-based MPC could fulfill the control objectives of power demand and indoor temperature simultaneously. Compared with RC-based MPC, the SVR-based MPC could alleviate the time/labor cost of model development without sacrificing the control performance of fast DR events

    Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study

    Get PDF
    OBJECTIVE To assess the association between macrolide antibiotics prescribing during pregnancy and major malformations, cerebral palsy, epilepsy, attention deficit hyperactivity disorder, and autism spectrum disorder in children. DESIGN Population based cohort study. SETTING The UK Clinical Practice Research Datalink. PARTICIPANTS The study cohort included 104 605 children born from 1990 to 2016 whose mothers were prescribed one macrolide monotherapy (erythromycin, clarithromycin, or azithromycin) or one penicillin monotherapy from the fourth gestational week to delivery. Two negative control cohorts consisted of 82 314 children whose mothers were prescribed macrolides or penicillins before conception, and 53 735 children who were siblings of the children in the study cohort. MAIN OUTCOME MEASURES Risks of any major malformations and system specific major malformations (nervous, cardiovascular, gastrointestinal, genital, and urinary) after macrolide or penicillin prescribing during the first trimester (four to 13 gestational weeks), second to third trimester (14 gestational weeks to birth), or any trimester of pregnancy. Additionally, risks of cerebral palsy, epilepsy, attention deficit hyperactivity disorder, and autism spectrum disorder. RESULTS Major malformations were recorded in 186 of 8632 children (21.55 per 1000) whose mothers were prescribed macrolides and 1666 of 95 973 children (17.36 per 1000) whose mothers were prescribed penicillins during pregnancy. Macrolide prescribing during the first trimester was associated with an increased risk of any major malformation compared with penicillin (27.65 v 17.65 per 1000, adjusted risk ratio 1.55, 95% confidence interval 1.19 to 2.03) and specifically cardiovascular malformations (10.60 v 6.61 per 1000, 1.62, 1.05 to 2.51). Macrolide prescribing in any trimester was associated with an increased risk of genital malformations (4.75 v 3.07 per 1000, 1.58, 1.14 to 2.19, mainly hypospadias). Erythromycin in the first trimester was associated with an increased risk of any major malformation (27.39 v 17.65 per 1000, 1.50, 1.13 to 1.99). No statistically significant associations were found for other system specific malformations or for neurodevelopmental disorders. Findings were robust to sensitivity analyses. CONCLUSIONS Prescribing macrolide antibiotics during the first trimester of pregnancy was associated with an increased risk of any major malformation and specifically cardiovascular malformations compared with penicillin antibiotics. Macrolide prescribing in any trimester was associated with an increased risk of genital malformations. These findings show that macrolides should be used with caution during pregnancy and if feasible alternative antibiotics should be prescribed until further research is available. TRIAL REGISTRATION ClinicalTrials.gov NCT0394862
    corecore